We have placed cookies on your computer to help make this website better. We use a PIWIK Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by PIWIK (e.g. deny use/opt-out).

I'm ok with this

Corporate publications | Resources | Media | Grünenthal Group

Corporate Publications

26 June 2019 / Our Stories

What chronic pain means to patients and society

Woman living in chronic pain
Pain is a huge burden. It impacts patients, their families, friends and caregivers — as well society as a whole. As a global leader in innovative pain management, Grünenthal is driven to seek new solutions to relieve pain.
people
1 in 5

or 1.4 billion people worldwide are affected by chronic pain5

chronic pain
21

% of chronic pain patients suffer for more than 20 years6

treatment
78

% of chronic pain patients state that their treatment was not as good as they expected7

 

It is estimated that about one in five people worldwide suffers from chronic pain1 , which equates to around 1.4 billion people. Pain is one of the most common reasons people seek medical help2 , which places an enormous economic burden on healthcare systems. For many conditions there is no standard of care, and in cases where they do exist, they have limited efficacy.3 Chronic pain is one of the major reasons why people leave the labour market prematurely, and is also a significant contributor to disability retirement.4

Given the prevalence and debilitating effects of pain, Grünenthal considers it to be a disease in its own right rather than just a symptom. As a global leader in pain management for nearly 50 years, we’re fully aware that patients are still hugely underserved in this area. We’re driven to seek new solutions to relieve pain. We are also fully committed to transforming this field. We’re redefining and shaping the future of pain management through our own research, as well as by drawing on external innovation, collaborations and networks.

“Although few people die of pain, many still die in pain, while even more live in pain. We will leave no stone unturned to help these patients.”

Gabriel Baertschi,

CEO of Grünenthal

 

Grünenthal’s unique commitment to pain

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. We are focussing all of our activities and efforts on moving towards our vision of a world free of pain.
 

Why pain matters

 

sick days
500

million sick days per day in Europe are due to musculoskeletal pain alone8

work incapacity
60

% of permanent work incapacity in Europe is due to musculoskeletal pain alone9

losses
34

billion euros loss for the European economy due to chronic pain10

[1]Goldberg D.S. and McGee S.J. Pain as a Global Public Health Priority. BMC Public Health. 2011;11:770.

[2] Gureje, O. Simon G.E. Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain. 2001 92(1-2):195-200.

[3] Pain Alliance Europe. Survey on Chronic Pain 2017, Diagnosis, Treatment and Impact of Pain [Internet]. Brussels: Pain Alliance Europe; 2017 p. 1-13. Available from: https://www.pae-eu.eu/wp-content/uploads/2017/12/PAE-Survey-on-Chronic-Pain-June-2017.pdf

[4]Saastamoinen P. et al. Pain and disability retirement: a prospective cohort study. Pain. 2012;153(3):526-531.

[5] Goldberg D.S. and McGee S.J. Pain as a Global Public Health Priority. BMC Public Health. 2011;11:770.

[6] Breivik H, et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain. 2006;10(4) :287-333.

[7] Pain Alliance Europe. Survey on Chronic Pain 2017, Diagnosis, Treatment and Impact of Pain [Internet]. Brussels: Pain Alliance Europe; 2017 p. 1-13. Available from: https://www.pae-eu.eu/wp-content/uploads/2017/12/PAE-Survey-on-Chronic-Pain-June-2017.pdf

[8] Bevan S. et al. Reducing Temporary Work Absence Through Early Intervention: The case of MSDs in the EU [Internet]. London: The Work Foundation; 2013 p. 2-10. Available from: http://www.theworkfoundation.com/DownloadPublication/Report/341_The%20case%20for%20early%20interventions%20on%20MSDs.pdf

[10] Wiffen P. Pain: there is a lot of it. Eur J Hosp Pharm. 2013;20(1):1-1

Share this Story: